LLY250502P692500
- 1.46
- +1.21+484.00%
Eli Lilly and Co Newsroom
Eli Lilly's Stock Selloff Is Overdone, Analysts Say. Here's Why.
Overview of international financial hot topics from last night to this morning_ May 3, 2025_ Financial news.
To view more global financial News, please move to the 7×24 hour real-time financial news market close: the S&P index has set a record for the longest consecutive rise in 20 years, with market attention on data and trade negotiation prospects. On May 2, the top 20 trading volumes of US stocks: Apple fell 3.7%, and the Earnings Reports highlight tariff and growth concerns. On Friday, China Concept Stocks rose broadly, with Taiwan Semiconductor up 3.81% and Alibaba up 4.35%. This week, Brent crude oil plummeted 8.3%, and Crude Oil fell 7.5%. Spot Gold fell 2.4% this week, and the Philadelphia Gold and Silver Index cumulatively declined over 3.5%. European stocks rose for nine consecutive days, nearing recovery of losses since the announcement of US tariffs.
Overnight news: U.S. stocks closed higher, Trump announced the 2026 budget plan, Bezos plans to sell $4.8 billion worth of Amazon stocks, Barclays and Goldman Sachs expect the Federal Reserve to lower interest rates in July.
To view more global financial News, please move to the 7×24 hour real-time financial news market close: the S&P index has set a record for the longest consecutive rise in 20 years, with market attention on data and trade negotiation prospects. On May 2, the top 20 trading volumes of US stocks: Apple fell 3.7%, and the Earnings Reports highlight tariff and growth concerns. On Friday, China Concept Stocks rose broadly, with Taiwan Semiconductor up 3.81% and Alibaba up 4.35%. This week, Brent crude oil plummeted 8.3%, and Crude Oil fell 7.5%. Spot Gold fell 2.4% this week, and the Philadelphia Gold and Silver Index cumulatively declined over 3.5%. European stocks rose for nine consecutive days, nearing recovery of losses since the announcement of US tariffs.
Express News | UBS Maintains Buy on Eli Lilly, Lowers Price Target to $1050
Eli Lilly Analyst Ratings
Eli Lilly and Co Options Spot-On: On May 2nd, 90,297 Contracts Were Traded, With 329.36K Open Interest
Fund Update: COMMERZBANK AKTIENGESELLSCHAFT /FI Added 31,915 Shares of ELI LILLY ($LLY) to Their Portfolio
Fund Update: COMMERZBANK AKTIENGESELLSCHAFT /FI Just Disclosed New Holdings
Novo Nordisk Says Oral Version of Wegovy Accepted for FDA Review
Eli Lilly (NYSE:LLY) Announces Promising Trial Data And Updates 2025 Guidance
Cigna to Launch Specialized GLP-1 Pharmacy Next Month
Eli Lilly's Zepbound Likely to Continue Uptake Despite CVS Decision, Truist Says
Eli Lilly's 'Untapped Volume' in Obesity Drug Counters CVS Setback, Deutsche Bank Says
Eli Lilly's Options Frenzy: What You Need to Know
Stronger-Than-Expected April Jobs Growth Lifts US Equity Futures Pre-Bell
Morgan Stanley Adjusts Price Target on Eli Lilly to $1,133 From $1,124
Goldman Sachs Adjusts Price Target on Eli Lilly to $883 From $888
UBS Adjusts Price Target on Eli Lilly to $1,050 From $1,100, Maintains Buy Rating
Fund Update: WHITTIER TRUST CO Added 23,186 Shares of ELI LILLY ($LLY) to Their Portfolio
Wells Fargo Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,100